Planet Labs PBC (PL) Down 5.1% — Should I Exit Before Things Get Worse?

Key Points


  • PL fell 5.07% to $33.25 from $35.02 previous close
  • Weiss Ratings assigns D (Sell)
  • Market cap is $12.12B

Planet Labs PBC (PL) retreated on the NYSE, falling 5.07% in the latest session and shedding $1.77 from the prior close. The decline put the stock under renewed pressure following a recent run higher, with sellers driving a pullback that stood out for its magnitude. Even within a broad 52-week range stretching from $2.79 to $37.05, the day's move pushed shares meaningfully off their recent peak and reinforced a choppy, risk-on/risk-off trading pattern.

Trading activity also pointed to waning conviction. Volume came in at 4,764,869 shares — well below the 90-day average of 13,538,178 — yet that lighter tape was still enough to accompany a sharp downdraft. PL now sits roughly $3.80, or about 10.3%, below its 52-week high of $37.05 set on 03/25/2026, underscoring how swiftly the stock has surrendered ground near the top of its yearly range. For investors tracking relative strength across the sector, the latest decline left PL showing clear near-term weakness against  established Industrials peers like Casella Waste Systems (CWST), KBR (KBR), and Booz Allen Hamilton (BAH), which tend to trade with far narrower single-session swings. Overall, the price action reads as defensive and fragile, with momentum facing stiff headwinds after failing to hold onto recent gains.


Why Planet Labs PBC Price is Moving Lower

Planet Labs PBC is moving lower as investors weigh a mix of genuinely strong operational headlines against persistent financial and valuation concerns. The company's record fiscal 2026 results highlighted accelerating demand — including $307.7M in full-year revenue, $86.8M in Q4 revenue (up 41% year over year), and $852M in Remaining Performance Obligations, up 106%. It also generated $134.4M in operating cash flow and $52.9M in free cash flow. Yet after a sharp rally over the past year, the market appears to be shifting its focus from celebrating growth to questioning what that growth ultimately means for shareholders — particularly with EPS still at -$0.79 and profitability deeply in the red.

Forward expectations may be adding to the pressure despite management's upbeat tone. The FY27 revenue outlook of $415M–$440M implies continued expansion, but the stock's pullback suggests investors want clearer evidence that scaling will narrow losses and improve margins — not simply grow the top line. A warrant redemption and continued investment in satellite services and AI analytics may further fuel near-term caution, as these moves can be read as dilutive or cash-intensive depending on their structure and timeline.

Trading dynamics are compounding the headwinds. Recent volatility has been elevated, and the stock has swung sharply even in response to strong quarterly results — a pattern that tends to invite quicker profit-taking. With analyst price targets frequently cited well below recent trading levels, sentiment can turn fragile quickly when momentum fades and investors reset their expectations around more conservative valuation frameworks.


What is the Planet Labs PBC Rating - Should I Sell?

Weiss Ratings assigns PL a D rating, with a current recommendation of Sell. The stock was last upgraded on 9/17/2024, though even with that upgrade, the overall risk/reward profile remains unfavorable — and shareholders have not been consistently shielded from downside swings.

A central concern is that operational progress has yet to translate into durable profitability. Revenue growth of 41.05% is impressive on its face, but it comes alongside a deeply negative profit margin of -80.22% and a forward P/E of -44.43 — both signs that the business remains far from generating reliable earnings. That reality is consistent with the Weak Growth Index and the Very Weak Efficiency Index, which together raise legitimate questions about cost control, returns on capital, and whether scaling can meaningfully improve the company's economics within a reasonable timeframe.

Supporters may point to the Excellent Total Return Index as a bright spot, but that strength can prove fragile when paired with the Weak Volatility Index. Put simply, past bursts of performance have carried a risk profile capable of punishing investors during broader market pullbacks or company-specific disappointments. The Good Solvency Index does provide some reassurance on the balance-sheet front, yet financial stability alone cannot offset weak operating efficiency and ongoing losses.

Within Industrials sector, Planet Labs sits alongside other lower-rated names such as Casella Waste Systems, Inc. (CWST, D) and KBR, Inc. (KBR, D+), and it trails peers like Booz Allen Hamilton Holding Corporation (BAH, D+). The bottom line: the upgrade does not change the core cautionary stance — this remains a higher-risk stock where strong top-line growth has not been sufficient to overcome weak profitability and an uneven performance record.


About Planet Labs PBC

Planet Labs PBC (PL) is an Industrials company in the Commercial and Professional Services industry that builds and operates satellite constellations to collect high-cadence geospatial data. Founded in 2010 and headquartered in San Francisco, Planet delivers imagery and related data products through an online platform to customers across the U.S. and internationally. Its business is built around transforming frequent Earth observation into actionable information for organizations that require timely visibility into physical conditions on the ground.

The company's fleet includes SuperDove satellites designed to image the Earth daily at up to 3.5-meter ground sampling distance (GSD) resolution, combining routine monitoring with scientific-grade radiometric data sourced from public satellite programs. For higher-resolution tasking, Planet offers SkySat and the next-generation Pelican satellites, which are engineered to revisit specific locations multiple times per day and can achieve up to 50-centimeter GSD resolution after processing. Planet also operates Tanager, a hyperspectral imaging satellite that produces full-spectrum imagery across visible and shortwave infrared wavelengths for applications requiring material and environmental detection.

Planet's Earth Observation platform supports image tasking, data discovery, and analytics delivery through APIs and browser-based tools, integrating smoothly with GIS workflows and custom-built solutions. Beyond its own data catalog, the company provides satellite services arrangements that span designing and manufacturing customer-owned satellites, mission systems engineering, launch procurement, ground station infrastructure, satellite operations, maintenance, and dedicated tasking capacity. Its end markets include agriculture, mapping, energy, forestry, finance, insurance, and government agencies.


Investor Outlook

With a Weiss Rating of D (Sell), Planet Labs PBC (PL) presents an unfavorable risk/reward setup. Investors may want to exercise caution and monitor for follow-through below recent support levels, as well as any failed rebound attempts. Broader Industrials sentiment bears watching, as does whether the company's operational progress ultimately delivers more consistent risk-adjusted returns — key factors that can keep a D rating in place even when the headlines improve. See full rankings of all D-rated Industrials stocks inside the Weiss Stock Screener.

--

This Weiss Instant News Alert was compiled by narrative data technology, our proprietary ratings models and analysis by Weiss Ratings with the intent of providing our readers with the fastest research and independent coverage. Weiss Instant News Alerts have been reviewed by a member of our editorial staff before publication. Please send any questions or comments about this story to [email protected]
Top Tech Stocks
See All »
B
NVDA NASDAQ $202.50
B
AAPL NASDAQ $273.17
B
MU NASDAQ $487.48
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $129.98
B
B
Top Financial Stocks
See All »
B
B
JPM NYSE $313.02
B
Top Energy Stocks
See All »
Top Health Care Stocks
See All »
B
LLY NYSE $921.48
B
JNJ NYSE $226.10
B
AMGN NASDAQ $345.92
Top Real Estate Stocks
See All »
B
VTR NYSE $80.10